Hitting statistical significance and proof of concept in phase II for bipolar mania, Rapport Therapeutics Inc. is moving to ...

Although a mediated settlement is already on the table awaiting court approval, the U.S. Court of Appeals for the Fifth Circuit breathed new life into Cassava Sciences Inc.’s fight to stave off a ...

Beating other PD-1 therapies to the finish line, GSK plc’s Jemperli (dostarlimab) secured accelerated approval from the U.S.

Labcorp Holdings Inc. appears to be on an acquisition spree. It has agreed to buy the Prenatal Health testing business of ...

At the United European Gastroenterology Week (UEGW) 2026 annual conference being held in Barcelona Oct. 17-20, a team of ...

New blood-based biomarker tests that detect Alzheimer’s before symptoms appear are poised to transform the clinical landscape by catching the disease when controlling for risk factors is known to have ...

Abbott Laboratories received CE mark certification for the Cologuard Plus, a stool-based DNA test designed to detect both colorectal cancer and advanced precancerous lesions. The test was developed by ...

Chengdu Kangnuoxing Biopharma Inc. and Keymed Biosciences Co. Ltd. have reported new protein/nucleic acid degraders comprising an E3 ubiquitin ligase-binding moiety covalently linked to a signal ...

Ensem Therapeutics Inc. has identified new phosphatidylinositol 3-kinase α (PI3Kα) inhibitors reported to be useful for the treatment of cancer.